HQL
NYSEabrdn Life Sciences Investors Shares of Beneficial Interest
Price$18.22+0.26 (+1.45%)
01:30 PM07:45 PM
News · 26 weeks8-100%
2025-11-092026-05-03
Mix290d
- Dividends2(100%)
Latest news
25 items- PRAberdeen Investments U.S. Closed-End Funds Announce Distribution Payment DetailsPHILADELPHIA, March 31, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on March 31, 2026, on a per share basis to all shareholders of record as of March 24, 2026 (ex-dividend date March 24, 2026). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and Aberdeen India Fund Inc. (IFN) which paid on March 31, 2026, to all shareholders of record as of February 20, 2026 (ex-dividend date Fe
- PRCertain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and AmountsPHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of rec
- PRAberdeen Investments U.S. Closed-End Funds Announce Distribution Payment DetailsPHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 12, 2026, on a per share basis to all shareholders of record as of December 31, 2025 (ex-dividend date December 31, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on January 12, 2026, to all shareholders of record as of November 21, 2025 (ex-dividend da
- INSIDERSEC Form 3 filed by new insider Reilly Heather Carter3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- INSIDERDirector Pittard Christian bought $133,755 worth of shares (7,923 units at $16.88) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SECSEC Form N-CSR filed by abrdn Life Sciences Investors Shares of Beneficial InterestN-CSR - abrdn Life Sciences Investors (0000884121) (Filer)
- SECSEC Form N-CEN filed by abrdn Life Sciences Investors Shares of Beneficial InterestN-CEN - abrdn Life Sciences Investors (0000884121) (Filer)
- PRABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILSPHILADELPHIA, Nov. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on November 28, 2025 to all shareholders of record as of November 21, 2025 (ex-dividend date November 21, 2025). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on January 12, 2026, to all shareholders of
- PRABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILSPHILADELPHIA, Sept. 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on September 30, 2025, on a per share basis to all shareholders of record as of September 23, 2025 (ex-dividend date September 23, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on September 30, 2025, to all shareholders of record as of August 22, 2025 (ex-divi
- INSIDERLarge owner Saba Capital Management, L.P. sold $687,094 worth of shares (48,612 units at $14.13) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- INSIDERLarge owner Saba Capital Management, L.P. sold $906,075 worth of shares (64,536 units at $14.04) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- INSIDERLarge owner Saba Capital Management, L.P. sold $38,235 worth of shares (2,726 units at $14.03) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- INSIDERLarge owner Saba Capital Management, L.P. sold $215,856 worth of shares (15,116 units at $14.28) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- INSIDERLarge owner Saba Capital Management, L.P. sold $197,725 worth of shares (14,083 units at $14.04) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- INSIDERLarge owner Saba Capital Management, L.P. sold $329,512 worth of shares (23,723 units at $13.89) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SECSEC Form N-PX filed by abrdn Life Sciences Investors Shares of Beneficial InterestN-PX - abrdn Life Sciences Investors (0000884121) (Filer)
- INSIDERLarge owner Saba Capital Management, L.P. sold $5,532 worth of shares (400 units at $13.83) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- INSIDERLarge owner Saba Capital Management, L.P. sold $150,690 worth of shares (10,710 units at $14.07) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- PRABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILSPHILADELPHIA, Aug. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 29, 2025 to all shareholders of record as of August 22, 2025 (ex-dividend date August 22, 2025). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on September 30, 2025, to all shareholders of reco
- INSIDERSEC Form 3 filed by new insider Dietrick Joseph Francis3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- PRABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILSPHILADELPHIA, June 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 30, 2025, on a per share basis to all shareholders of record as of June 23, 2025 (ex-dividend date June 23, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on June 30, 2025, to all shareholders of record as of May 22, 2025 (ex-dividend date May 22, 2025).
- SECSEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial InterestN-CSRS - abrdn Life Sciences Investors (0000884121) (Filer)
- PRABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERSPHILADELPHIA, May 28, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds announced they each held their Annual Meeting of Shareholders (the "Meetings") on May 28, 2025. At the Meetings, shareholders of the respective Funds voted on the proposals set forth below: abrdn Asia-Pacific Income Fund, Inc. ("FAX")As of the record date, April 7, 2025, FAX had outstanding 41,282,628 shares of common stock and 4,000,000 shares of preferred stock. 60.36% of outstanding common stock and 100% of preferred stock were voted representing a quorum. To elect one Clas
- INSIDERLarge owner Saba Capital Management, L.P. sold $145,135 worth of shares (11,419 units at $12.71) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- INSIDERLarge owner Saba Capital Management, L.P. sold $286,646 worth of shares (23,729 units at $12.08) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
HQL FAQ
7 questionsWhat does abrdn Life Sciences Investors Shares of Beneficial Interest do?
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs...Where does HQL stock trade?
abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) is listed on NYSE.What sector and industry is HQL in?
abrdn Life Sciences Investors Shares of Beneficial Interest operates in the Finance sector, Investment Managers industry.When did abrdn Life Sciences Investors Shares of Beneficial Interest go public?
abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) completed its IPO in 1992.Does HQL pay a dividend?
HQL's most recent ex-dividend date was 2026-02-20 with a cash dividend of $0.56 per share. No future ex-date is on file yet.What companies are similar to HQL?
Notable peers in the same industry include BX (Blackstone Inc.), KKR (KKR & Co. Inc.), APO (Apollo Global Management Inc. (New)), AMP (Ameriprise Financial Inc.), ARES (Ares Management Corporation). Compare HQL side-by-side with any of them on Quantisnow.How can I track HQL on Quantisnow?
Quantisnow aggregates abrdn Life Sciences Investors Shares of Beneficial Interest's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HQL to receive live email and push alerts on every new disclosure.